Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis
…, A Musubire, K Taseera, HW Nabeta… - … England Journal of …, 2014 - Mass Medical Soc
Background Cryptococcal meningitis accounts for 20 to 25% of acquired immunodeficiency
syndrome–related deaths in Africa. Antiretroviral therapy (ART) is essential for survival; …
syndrome–related deaths in Africa. Antiretroviral therapy (ART) is essential for survival; …
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study
…, BM Morawski, KH Hullsiek, HW Nabeta… - The Lancet infectious …, 2016 - thelancet.com
Background Cryptococcus is the most common cause of adult meningitis in Africa. We assessed
the safety and microbiological efficacy of adjunctive sertraline, previously shown to have …
the safety and microbiological efficacy of adjunctive sertraline, previously shown to have …
The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis
…, KH Hullsiek, J Rhein, HW Nabeta… - Clinical infectious …, 2014 - academic.oup.com
Introduction. Cryptococcal meningitis is the most common cause of adult meningitis in sub-Saharan
Africa. Raised intracranial pressure (ICP) is common in cryptococcosis. Prior studies …
Africa. Raised intracranial pressure (ICP) is common in cryptococcosis. Prior studies …
Immunity to commensal papillomaviruses protects against skin cancer
…, ME Awad, T Li, T Hasegawa, DT Ha, HW Nabeta… - Nature, 2019 - nature.com
Immunosuppression increases the risk of cancers that are associated with viral infection 1 .
In particular, the risk of squamous cell carcinoma of the skin—which has been associated …
In particular, the risk of squamous cell carcinoma of the skin—which has been associated …
Serum vitamin D status in children with protein-energy malnutrition admitted to a national referral hospital in Uganda
HW Nabeta, J Kasolo, RK Kiggundu, AN Kiragga… - BMC research …, 2015 - Springer
Background Vitamin D deficiency is a world-wide epidemic with recent estimates indicating
that greater than 50 % of the global population is at risk. In Uganda, 80 % of healthy …
that greater than 50 % of the global population is at risk. In Uganda, 80 % of healthy …
Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis
…, J Rhein, BM Morawski, R Kiggundu, HW Nabeta… - …, 2016 - academic.oup.com
Quantitative cerebrospinal fluid (CSF) cultures provide a measure of disease severity in
cryptococcal meningitis. The fungal clearance rate by quantitative cultures has become a …
cryptococcal meningitis. The fungal clearance rate by quantitative cultures has become a …
Accuracy of noninvasive intraocular pressure or optic nerve sheath diameter measurements for predicting elevated intracranial pressure in cryptococcal meningitis
Background. Cryptococcal meningitis is associated with increased intracranial pressure (ICP).
Therapeutic lumbar puncture (LP) is recommended when the initial ICP is >250 mm H 2 O…
Therapeutic lumbar puncture (LP) is recommended when the initial ICP is >250 mm H 2 O…
Novel antifungal activity of Q-Griffithsin, a broad-spectrum antiviral lectin
HW Nabeta, JC Kouokam, AB Lasnik… - Microbiology …, 2021 - Am Soc Microbiol
There is a rising global incidence of Candida strains with high levels of resistance to fluconazole
and other antifungal drugs, hence the need for novel antifungal treatment strategies. …
and other antifungal drugs, hence the need for novel antifungal treatment strategies. …
Cytomegalovirus viremia associated with increased mortality in cryptococcal meningitis in sub-Saharan Africa
…, K Taseera, HW Nabeta… - Clinical Infectious …, 2020 - academic.oup.com
Background Cryptococcal meningitis and tuberculosis are both important causes of death in
persons with advanced human immunodeficiency virus (HIV)/acquired immunodeficiency …
persons with advanced human immunodeficiency virus (HIV)/acquired immunodeficiency …
Cerebrospinal fluid early fungicidal activity as a surrogate endpoint for cryptococcal meningitis survival in clinical trials
…, R Kiggundu, A Akampurira, HW Nabeta… - Clinical Infectious …, 2020 - academic.oup.com
Background In cryptococcal meningitis phase 2 clinical trials, early fungicidal activity (EFA)
of Cryptococcus clearance from cerebrospinal fluid (CSF) is used as a surrogate endpoint for …
of Cryptococcus clearance from cerebrospinal fluid (CSF) is used as a surrogate endpoint for …